Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity.
Kataoka Y, Tanabe N, Shirata M, Hamao N, Oi I, Maetani T, Shiraishi Y, Hashimoto K, Yamazoe M, Shima H, Ajimizu H, Oguma T, Emura M, Endo K, Hasegawa Y, Mio T, Shiota T, Yasui H, Nakaji H, Tsuchiya M, Tomii K, Hirai T, Ito I. Kataoka Y, et al. Among authors: tomii k. Respir Res. 2024 Jan 10;25(1):24. doi: 10.1186/s12931-024-02673-w. Respir Res. 2024. PMID: 38200566 Free PMC article.
Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.
Isozumi R, Ito Y, Ishida T, Osawa M, Hirai T, Ito I, Maniwa K, Hayashi M, Kagioka H, Hirabayashi M, Onari K, Tomioka H, Tomii K, Gohma I, Imai S, Takakura S, Iinuma Y, Ichiyama S, Mishima M; Kansai Community Acquired Pneumococcal Pneumonia Study Groupe. Isozumi R, et al. Among authors: tomii k. J Clin Microbiol. 2007 May;45(5):1440-6. doi: 10.1128/JCM.01430-06. Epub 2007 Mar 7. J Clin Microbiol. 2007. PMID: 17344362 Free PMC article.
Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902.
Kim YH, Hirabayashi M, Togashi Y, Hirano K, Tomii K, Masago K, Kaneda T, Yoshimatsu H, Otsuka K, Mio T, Tomioka H, Suzuki Y, Mishima M. Kim YH, et al. Among authors: tomii k. Cancer Chemother Pharmacol. 2012 Aug;70(2):271-6. doi: 10.1007/s00280-012-1910-2. Epub 2012 Jun 30. Cancer Chemother Pharmacol. 2012. PMID: 22752216 Clinical Trial.
Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Izuhara Y, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M. Kanemitsu Y, et al. Among authors: tomii k. J Allergy Clin Immunol. 2013 Aug;132(2):305-12.e3. doi: 10.1016/j.jaci.2013.04.050. Epub 2013 Jun 19. J Allergy Clin Immunol. 2013. PMID: 23791506 Free article.
GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.
Izuhara Y, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K, Fujimura M, Ohkura N, Tomita K, Yokoyama A, Ohnishi H, Nakano Y, Oguma T, Hozawa S, Nagasaki T, Ito I, Oguma T, Inoue H, Tajiri T, Iwata T, Ono J, Ohta S, Tamari M, Hirota T, Yokoyama T, Niimi A, Mishima M. Izuhara Y, et al. Among authors: tomii k. Allergy. 2014 May;69(5):668-73. doi: 10.1111/all.12400. Epub 2014 Mar 27. Allergy. 2014. PMID: 24673601
Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma.
Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, Kita H, Tomii K, Fujimura M, Yokoyama A, Nakano Y, Hozawa S, Ito I, Oguma T, Izuhara Y, Tajiri T, Iwata T, Ono J, Ohta S, Yokoyama T, Niimi A, Mishima M. Nagasaki T, et al. Among authors: tomii k. Am J Respir Crit Care Med. 2014 Dec 15;190(12):1449-52. doi: 10.1164/rccm.201407-1290LE. Am J Respir Crit Care Med. 2014. PMID: 25496105 No abstract available.
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study.
Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. Fujimoto D, et al. Among authors: tomii k. Lung Cancer. 2018 May;119:14-20. doi: 10.1016/j.lungcan.2018.02.017. Epub 2018 Mar 2. Lung Cancer. 2018. PMID: 29656747
Pseudoprogression in Previously Treated Patients with Non-Small Cell Lung Cancer Who Received Nivolumab Monotherapy.
Fujimoto D, Yoshioka H, Kataoka Y, Morimoto T, Hata T, Kim YH, Tomii K, Ishida T, Hirabayashi M, Hara S, Ishitoko M, Fukuda Y, Hwang MH, Sakai N, Fukui M, Nakaji H, Morita M, Mio T, Yasuda T, Sugita T, Hirai T. Fujimoto D, et al. Among authors: tomii k. J Thorac Oncol. 2019 Mar;14(3):468-474. doi: 10.1016/j.jtho.2018.10.167. Epub 2018 Nov 20. J Thorac Oncol. 2019. PMID: 30468872 Free article.
387 results